4
Changes in Ownership
ORAMED PHARMACEUTICALS INC. Filed Acc 0001213900-26-075070
COO & CBO sold 137,000 shares at $4.46 ($611,431)
- COO & CBO acquired 50,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Hexter Joshua COO & CBO | 2026-07-01 | Sale | −137,000 | $4.46 | $611,431 | 1,023,384 | D |
| Hexter Joshua COO & CBO | 2026-07-02 | Option exercise | +50,000 | $3.69 | $184,500 | 1,073,384 | D |
| Derivatives | |||||||
| Hexter Joshua COO & CBO | 2026-07-02 | Option exercise · Stock option (right to buy) | −50,000 | 50,000 | D | ||
| Open-market sales · 137,000 sh · avg $4.46 · $611,431 | |||||||
Loading xslF345X06/ownership.xml…